{"id":3836,"date":"2025-03-31T18:11:50","date_gmt":"2025-03-31T18:11:50","guid":{"rendered":"https:\/\/kidneydiseaseclinic.net\/kdc\/cidofovir-txt\/"},"modified":"2025-03-31T18:11:50","modified_gmt":"2025-03-31T18:11:50","slug":"cidofovir-txt","status":"publish","type":"post","link":"https:\/\/kidneydiseaseclinic.net\/kdc\/cidofovir-txt\/","title":{"rendered":"Cidofovir.txt"},"content":{"rendered":"<h1>Cidofovir<\/h1>\n<p><H3>  CLINICAL USE <\/H3><br \/>\nTreatment of CMV retinitis in patients  with AIDS, if other agents are unsuitableTreatment of BK polyoma virus in  transplant patients (unlicensed)<H3> DOSE IN NORMAL RENAL FUNCTION  <\/H3>5 mg\/kg weekly for 2 weeks then once every 2 weeks(See further information for BK polyoma virus treatment)<H3>  PHARMACOKINETICS    <\/H3><LI> Molecular weight &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :279.2<\/li>\n<li>  %Protein binding  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp  &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :&lt;6<\/li>\n<li>  %Excreted unchanged in urine &amp;nbsp &amp;nbsp : 80\u2013100<\/li>\n<p><LI> Volume of distribution (L\/kg) &amp;nbsp &amp;nbsp &amp;nbsp :0.3\u20130.8<\/li>\n<p><LI>half-life \u2013 normal\/ESRD (hrs)&amp;nbsp &amp;nbsp &amp;nbsp :1.7\u20132.7\/16\u2013251<H3>  DOSE IN RENAL IMPAIRMENT <\/H3> <H4>GFR (mL\/MIN)<\/H4>&gt;55 Dose as in normal renal function&lt;55 Avoid. See \u2018Other Information\u2019<H3> DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES  <\/H3><LI> CAPD  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp:Not dialysed. 0.5 mg\/kg\/dose<\/p>\n<li> HD &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :Dialysed. 0.5 mg\/kg\/dose<LI>HDF\/high flux  &amp;nbsp :Dialysed. 0.5 mg\/kg\/dose<LI>CAV\/VVHD  &amp;nbsp &amp;nbsp &amp;nbsp:Unknown dialysability. 0.5 mg\/kg\/dose<H3> IMPORTANT DRUG INTERACTIONS  <\/H3>Potentially hazardous interactions with other drugsNone known <H3> ADMINISTRATION  <\/H3><H4> Reconstition<\/H4>\u2013<H4>  Route  <\/H4><H4> IV infusion  <\/H4> <H4>  Rate of Administration  <\/H4>Over 60 minutes <H4>Comments<\/H4>Dilute in 100 mL sodium chloride 0.9% <H4>  OTHER INFORMATION  <\/H4>Always administer with oral probenecid  and intravenous sodium chloride 0.9%Administer 2 hours before dialysis session  to benefit from peak concentration without having delayed clearance52\u201375% of dose dialysed out with high- flux haemodialysisInformation for the treatment of BK  polyoma virus in transplant patients is from Pittsburgh. Starting dose was 0.25 mg\/kg (if GFR&lt;30 mL\/min) in 100 mL sodium chloride 0.9% administered over 1 hour, given every 10\u201314 days. Hydration pre- and post-dose with 1 litre of sodium chloride 0.9% if tolerated. If no change within 10\u201314 days increase to 0.3\u20130.5 mg\/kg; dose can be increased up to 1 mg\/kg depending on response and side effects. Most patients would need a cumulative dose of 1\u20131.5 mg\/kg. Initially use without probenecid. Monitor blood and urine samples for PCR measurement of viral load. The manufacturer advises to avoid in renal  failure but theoretical doses, based on a 70 kg person, are suggested in the following paper<br \/>\n","protected":false},"excerpt":{"rendered":"<p>Cidofovir CLINICAL USE Treatment of CMV retinitis in patients with<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7],"class_list":["post-3836","post","type-post","status-publish","format-standard","hentry","category-blog","tag-post-by-auto-php"],"_links":{"self":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/3836","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/comments?post=3836"}],"version-history":[{"count":0,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/3836\/revisions"}],"wp:attachment":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/media?parent=3836"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/categories?post=3836"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/tags?post=3836"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}